Free Access
Editorial
| Issue |
Med Sci (Paris)
Volume 35, Number 12, Décembre 2019
Anticorps monoclonaux en thérapeutique
|
|
|---|---|---|
| Page(s) | 924 - 925 | |
| Section | Éditorial | |
| DOI | https://doi.org/10.1051/medsci/2019244 | |
| Published online | 06 January 2020 | |
- DiMasi JA, Grabowski HG, Hansen RW , Innovation in the pharmaceutical industry: New estimates of R&D costs. J Health Econ. 2016;47:20–33. [CrossRef] [PubMed] [Google Scholar]
- Kaplon H, Reichert JM , Antibodies to watch in 2019. MAbs. 2019;11:219–238. [CrossRef] [PubMed] [Google Scholar]
- Beck A , Biosimilar, biobetter and next generation therapeutic antibodies. MAbs. 2011;3:107–110. [CrossRef] [PubMed] [Google Scholar]
- Beck A, Reichert JM , Approval of the first biosimilar antibodies in Europe: a major landmark for the biopharmaceutical industry. MAbs. 2013;5:621–623. [CrossRef] [PubMed] [Google Scholar]
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.